Literature DB >> 34023527

The burden of OA-health services and economics.

V P Leifer1, J N Katz2, E Losina3.   

Abstract

Osteoarthritis (OA) is a highly prevalent and disabling condition that affects over 7% of people globally (528 million people). Prevalence levels are even higher in countries with established market economies, which have older demographic profiles and a higher prevalence of obesity, such as the US (14%). As the 15th highest cause of years lived with disability (YLDs) worldwide, the burden OA poses to individuals is substantial, characterized by pain, activity limitations, and reduced quality of life. The economic impact of OA, which includes direct and indirect (time) costs, is also substantial, ranging from 1 to 2.5% of gross national product (GNP) in countries with established market economies. In regions around the world, the average annual cost of OA for an individual is estimated between $700-$15,600 (2019 USD). Though trends in OA prevalence vary by geography, the prevalence of OA is projected to rise in regions with established market economies such as North America and Europe, where populations are aging and the prevalence of obesity is rising.
Copyright © 2021 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Direct medical costs of osteoarthritis; Epidemiology of osteoarthritis; Health services; Indirect medical costs of osteoarthritis; Individual and societal burdens of osteoarthritis; Osteoarthritis

Mesh:

Year:  2021        PMID: 34023527      PMCID: PMC8605034          DOI: 10.1016/j.joca.2021.05.007

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  65 in total

Review 1.  The epidemiology of osteoarthritis in Asia.

Authors:  Marlene Fransen; Lisa Bridgett; Lyn March; Damian Hoy; Ester Penserga; Peter Brooks
Journal:  Int J Rheum Dis       Date:  2011-05       Impact factor: 2.454

2.  Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.

Authors:  Peter J Neumann; Joshua T Cohen; Milton C Weinstein
Journal:  N Engl J Med       Date:  2014-08-28       Impact factor: 91.245

3.  Effect of intensive diet and exercise on self-efficacy in overweight and obese adults with knee osteoarthritis: The IDEA randomized clinical trial.

Authors:  Shannon L Mihalko; Phillip Cox; Daniel P Beavers; Gary D Miller; Barbara J Nicklas; Mary Lyles; David J Hunter; Felix Eckstein; Ali Guermazi; Richard F Loeser; Paul DeVita; Stephen P Messier
Journal:  Transl Behav Med       Date:  2019-03-01       Impact factor: 3.046

4.  Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans.

Authors:  Elena Losina; Rochelle P Walensky; William M Reichmann; Holly L Holt; Hanna Gerlovin; Daniel H Solomon; Joanne M Jordan; David J Hunter; Lisa G Suter; Alexander M Weinstein; A David Paltiel; Jeffrey N Katz
Journal:  Ann Intern Med       Date:  2011-02-15       Impact factor: 25.391

5.  Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA.

Authors:  Louise M A Braakman-Jansen; Erik Taal; Ina H Kuper; Mart A F J van de Laar
Journal:  Rheumatology (Oxford)       Date:  2011-12-16       Impact factor: 7.580

Review 6.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.

Authors:  W Zhang; R W Moskowitz; G Nuki; S Abramson; R D Altman; N Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell
Journal:  Osteoarthritis Cartilage       Date:  2008-02       Impact factor: 6.576

7.  Projected Burden of Osteoarthritis and Rheumatoid Arthritis in Australia: A Population-Level Analysis.

Authors:  Ilana N Ackerman; Clare Pratt; Alexandra Gorelik; Danny Liew
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-04-12       Impact factor: 4.794

Review 8.  Ageing populations: the challenges ahead.

Authors:  Kaare Christensen; Gabriele Doblhammer; Roland Rau; James W Vaupel
Journal:  Lancet       Date:  2009-10-03       Impact factor: 79.321

Review 9.  Can Osteoarthritis Predict Mortality?

Authors:  Rebecca J Cleveland; Leigh F Callahan
Journal:  N C Med J       Date:  2017 Sep-Oct

10.  The epidemiology and impact of pain in osteoarthritis.

Authors:  T Neogi
Journal:  Osteoarthritis Cartilage       Date:  2013-09       Impact factor: 6.576

View more
  5 in total

1.  I don't know what type of arthritis I have: A population-based comparison of people with arthritis who knew their specific type and those who didn't.

Authors:  Elizabeth M Badley; Jessica M Wilfong; Christina H Chan; Mayilee Canizares; Anthony V Perruccio
Journal:  PLoS One       Date:  2022-06-21       Impact factor: 3.752

Review 2.  Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs).

Authors:  Win Min Oo; David J Hunter
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-20       Impact factor: 3.625

3.  Content, Structure and Delivery Characteristics of Yoga Interventions for the Management of Osteoarthritis: A Systematic Review Protocol.

Authors:  Isha Biswas; Sarah Lewis; Kaushik Chattopadhyay
Journal:  Int J Environ Res Public Health       Date:  2022-05-10       Impact factor: 4.614

Review 4.  Integrins, cadherins and channels in cartilage mechanotransduction: perspectives for future regeneration strategies.

Authors:  Martin Philipp Dieterle; Ayman Husari; Bernd Rolauffs; Thorsten Steinberg; Pascal Tomakidi
Journal:  Expert Rev Mol Med       Date:  2021-10-27       Impact factor: 5.600

Review 5.  Protective Effect of Resveratrol on Knee Osteoarthritis and its Molecular Mechanisms: A Recent Review in Preclinical and Clinical Trials.

Authors:  Shenglei Yang; Mingli Sun; Xinan Zhang
Journal:  Front Pharmacol       Date:  2022-07-25       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.